Global Coronary Heart Disease Diagnostic Imaging Devices Market

The coronary heart disease diagnostic imaging devices market is projected to grow at a CAGR of ~7% over the forecast period. Major factors driving growth include the rising prevalence of coronary heart diseases, growth in the geriatric population, technological advancements in imaging devices, growing demand for non-invasive diagnostic techniques, adoption of sedentary lifestyles worldwide, rising awareness and early diagnosis of coronary heart disease, and increased R&D investments and grants for cardiovascular research. Coronary Heart Disease (CHD) diagnostic imaging devices are medical technologies designed to generate detailed images of the heart, aiding in the diagnosis of CHD, a condition caused by plaque buildup in the coronary arteries, leading to reduced blood flow. These devices enable healthcare professionals to examine heart structures, evaluate blood circulation, and identify blockages or abnormalities in the coronary arteries. CHD diagnostic imaging technologies include X-ray machines, CT scanners, MRIs, and other advanced imaging systems that provide clear visualization of the heart and blood vessels. Download a free sample report for in-depth market insights https://meditechinsights.com/coronary-heart-disease-diagnostic-imaging-devices-market/request-sample/ Growing demand for non-invasive diagnostic techniques fuels its demand With continuous technological advancements, non-invasive imaging has become essential not only for diagnosing Coronary Heart Disease (CHD) but also for guiding treatment decisions, assessing prognosis, and optimizing cost-effective, value-based care. Unlike traditional invasive procedures such as catheter-based coronary angiography, which pose risks of complications, extended recovery times, and higher medical expenses, advanced non-invasive imaging techniques including CT Coronary Angiography (CCTA), Cardiac MRI, Echocardiography, and Nuclear Imaging—offer safer, faster, and more precise diagnostic solutions. These modalities provide both functional and anatomical insights into coronary artery blockages, blood flow, and heart function, allowing for accurate disease assessment without surgical intervention. With increasing awareness of early CHD detection, growing healthcare investments, and the expanding use of AI-powered imaging technologies, demand for non-invasive diagnostic imaging is expected to rise significantly, further driving market growth. Rising prevalence of CHD drives market growth Coronary Heart Disease (CHD) is the most prevalent cardiovascular disease (CVD), causing nearly 9 million deaths annually, as reported by the World Health Organization (WHO). Its rising incidence is driven by factors such as an aging population, increasing obesity rates, diabetes, and hypertension. Additionally, urbanization and modern lifestyle changes have contributed to higher stress levels, unhealthy diets, and reduced physical activity, further elevating CHD risk. Since CHD often develops silently, with symptoms emerging in later stages, early detection through CHD imaging devices is essential. Accurate and timely diagnosis enables healthcare providers to make well-informed decisions, improving patient care by facilitating the development of optimal treatment plans. Furthermore, CHD imaging devices play a crucial role in monitoring disease progression, assessing treatment effectiveness, and detecting other cardiovascular conditions, fueling their growing demand. Competitive Landscape Analysis The global coronary heart disease diagnostic imaging devices market is marked by the presence of established and emerging market players such as Canon Medical Systems; Esaote SPA; FUJIFILM Holdings Corporation; GE Healthcare; Hitachi Medical Corporation; Koninkilijhe Phillips N. V.; SAMSUNG; Siemens Healthineers AG; Ziehm Imaging GmbH; Carestream Health; Shimadzu Corporation; Bracco Imaging S.p.A.; and Hologic, Inc.; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and investments. Unlock key data with a sample report for competitive analysis: https://meditechinsights.com/coronary-heart-disease-diagnostic-imaging-devices-market/request-sample/ Global Coronary Heart Disease Diagnostic Imaging Devices Market Segmentation This report by Medi-Tech Insights provides the size of the global coronary heart disease diagnostic imaging devices market at the regional- and country-level from 2023 to 2030. The report further segments the market based on modality and end user. Market Size & Forecast (2023-2030), By Modality, USD Million Computed Tomography (CT) X rays Angiography (Fluoroscopy) Ultrasound (Echocardiography) Magnetic Resonance Imaging (MRI) Nuclear Imaging (PET & SPECT) Market Size & Forecast (2023-2030), By End User, USD Million Hospitals Ambulatory Surgical Centers (ASCs) Diagnostic Imaging Centers Others Market Size & Forecast (2023-2030), By Region, USD Million North America US Canada Europe UK Germany France Italy Spain Rest of Europe Asia Pacific China India Japan Rest of Asia Pacific Latin America Middle East & Africa About Medi-Tech Insights Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers. Contact: Ruta Halde Associate, Medi-Tech Insights +32 498 86 80 79 info@meditechinsights.com

Tag: Global Coronary Heart Disease Diagnostic Imaging Devices Market

Global Coronary Heart Disease Diagnostic Imaging Devices Market to Witness 7% CAGR Growth by 2030

Global Consumer Healthcare Market projected to rise at 8% CAGR amid wellness shift by 2030

Bioreactors Market to grow at ~7% CAGR with rising production of monoclonal antibodies by 2030

Clinical Trial Supplies Market driven by ~8% CAGR as biologics and rare disease trials rise by 2026

Optical Imaging Market to grow at 12% CAGR supported by increasing chronic diseases by 2029

Nanopore Sequencing Market grows 11% CAGR as DNA tech democratizes by 2030

Global Injection Pen Market Expanding with Auto-Injector Innovation and Aging Users by 2030

Global Research Antibodies and Reagents Market expands with rise in personalized care till 2030

Global Orthopedic Surgical Robots Market uplifted by demand for reduced recovery time by 2030

Global Biotechnology Market to achieve 13–15% CAGR as AI transforms biotech research by 2029

Allergy Treatment Market to grow 6–7% CAGR supported by early detection technologies by 2029